We observed that immunostimulatory chemokines such as CXCL9, CXCL10, CXCL11, CCL4, and CCL5 were consistently down‐regulated for the tumors with high Hh activity across the 14 cancer types. This evidence concerns the gene CXCL9 and cancer.